Stomach Cancer Clinical Trials in Tampa, FL
Stomach cancer clinical trials are important research studies that allow physicians to assess the effectiveness of newly discovered treatments as compared to the current standard of care. Many individuals who are being treated for stomach cancer through the Gastrointestinal Oncology Program at Moffitt Cancer Center in Tampa, FL, have opportunities to participate in these groundbreaking studies. At Moffitt, we help our patients make fully informed treatment decisions and encourage them to explore all of their options. In some cases, this may include promising new therapies that are currently available only through clinical trials.
As the only National Cancer Institute-designated Comprehensive Cancer Center based in Florida, Moffitt’s reputation as a leader in cancer research extends far beyond the Tampa area. Our robust portfolio of stomach cancer clinical trials, which has led to several important treatment breakthroughs, is overseen by a multispecialty team of experts who help to ensure that each patient receives highly individualized treatment. Some examples of our recent clinical trial subjects include:
- New chemotherapy medications
- Combinations of new and conventional chemotherapy drugs
- Targeted drugs (which capitalize on the differences between cancerous cells and healthy cells, helping to destroy tumors with damaging healthy tissue)
- Immunotherapies (which boost the body’s natural immune system to help it fight cancer)
- Tumor imaging techniques
Moffitt’s cancer research studies play a pivotal role in advancing cancer treatments for all current and future patients. In fact, all of today’s most effective stomach cancer treatments were once available only through clinical trials.
If you’d like to learn more about the stomach cancer clinical trials available in Tampa, FL, at Moffitt Cancer Center, call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form online. No referrals are necessary to consult with our clinical trial navigators, who may match you with a clinical trial that is appropriate for your needs.
Stomach (Gastric) Cancer
- Adrenal Cancer
- Anal Cancer
- Appendiceal (Appendix) Cancer
- Astrocytoma
- Basal Cell Carcinoma
- Bladder Cancer
- Bone Metastasis
- Brain Cancer
- Brain Tumor
- Breast Cancer
- Cervical Cancer
- Cholangiocarcinoma (Bile Duct Cancer)
- Colon Cancer
- Colorectal Cancer
- Cutaneous T-Cell Lymphoma
- Ductal Carcinoma In Situ
- Endometrial (Uterine) Cancer
- Esophageal Cancer
- Gallbladder Cancer
- Gastrointestinal Carcinoid Tumor
- GIST (Gastrointestinal Stromal Tumor)
- Glioblastoma
- Head and Neck Cancer
- HER2 Positive Breast Cancer
- Hodgkin Lymphoma
- Inflammatory Breast Cancer
- Invasive Ductal Carcinoma
- Kidney (Renal Cell) Cancer
- Leukemia
- Liver (Hepatocellular) Cancer
- Low-Grade Glioma
-
Lung Cancer
- Signs and Symptoms
- Diagnosis
- Treatment
- FAQs
- Lung Cancer Early Detection Center
- Lung Cancer Screening and Surveillance Program
- Lung Nodules
- Lung Surveillance Clinic
- Metastatic Lung Cancer
- Recurrence
- Survival Rate
- Your Lung Cancer Specialists
- Lung and Thoracic Tumor Education (LATTE)
- Thoracic Clinic Updates
- Insurance & Financial Information
- Lymphomas (Hodgkin and Non-Hodgkin)
- Melanoma
- Meningioma
- Merkel Cell Carcinoma
- Mesothelioma
- Metastatic Breast Cancer
- Multiple Myeloma-Plasma Cell Tumor
- Myelodysplastic Syndromes (MDS)
- Neuroendocrine Tumor
- Neurofibromatosis
- Non-Hodgkin Lymphoma
- Oral Cavity (Mouth) Cancer
- Oral Cavity or Throat Cancer
- Osteosarcoma
- Ovarian Cancer
- Pancoast Tumor
- Pancreatic Cancer
- Penile Cancer
- Pituitary Adenoma
- Prostate Cancer
- Rectal Cancer
- Sarcoma
- Skin Cancer (Nonmelanoma)
- Skull Base Tumors
- Small Intestine Cancer
- Spinal Tumor
- Squamous Cell Carcinoma
- Stomach (Gastric) Cancer
- Testicular Cancer
- Throat Cancer
- Thymoma
- Thyroid Cancer
- Tongue Cancer
- Tracheal Cancer
- Triple Negative Breast Cancer
- Vaginal Cancer
- Vulvar Cancer